Blue Horseshoe Stocks: BIND Recap & More

BIND Therapeutics, Inc. BIND

BIND cropped up on our premarket scanner yesterday in the wake of a post-market PR on Wednesday afternoon, and it put forth a solid move early in the session. It traded as low as 7.40 at the open, and we then witnessed a significant 36% spike to the high-of-day at 10.04.

That initial run was fueled by the release of positive Phase-2 results from one of the company’s many cancer treatments currently in various trial phases, and additionally, an update on guidance for 2015.  >>> READ PR

According to the CEO, BIND expects 2015 “to be a particularly active period” with regard to the development of its many products, so this will be a play that we’ll want to monitor more closely moving forward.

Toward the end of the session yesterday BIND pulled back, and is gapping once again in the pre-market, so we have our eyes peeled for any potential bounce action that could be used in our favor.


Twitter, Inc. TWTR – Options

We’ve also got to update everyone on the options trading idea we put forth earlier this week for TWTR. We mentioned an interest in the Weekly $38 and $39 Calls, and each set of contracts showed us a huge spike during yesterday’s session.

The $38’s traded in a range from .23-1.22, for a chance at monstrous gains of up to 430%, while the $39’s did even better as they ripped from .09 to a high of .54, a move totaling 500%

We also wanted to remind readers of the long-term options idea for TWTR we mentioned in the same report. The February $40 Calls could be in line for significant gains if TWTR continues to recover off of recent lows in the $35-36 range.


Extended Watchlist:
AGEN, CERE, ARNA, SD, NVAX, CARA

Blue Horseshoe Stocks: ARNA Recap & More

Arena Pharmaceuticals, Inc. ARNA

You have to go a long way back to find our very first coverage of ARNA. It was May 11th, 2012 that we first mentioned this stock as an item to have on long-term watch. At that time the company had an obesity treatment that was awaiting FDA approval.

The public sentiment during that summer was that FDA approval was all but in the bag, and as we waited the stock began a monstrous run from a low of 5.44 to the day of its approval when it hit 13.50, an overall increase of 148% It would be a very long time before we talked about ARNA again.

The next time was fairly recently on November 3rd when we included ARNA on our Extended Watchlist, and over a period of a few sessions, saw the stock make a decent move from a low of 4.12 to 4.76. After that, it endured a series of incremental pullbacks over the next several weeks.

Yesterday morning, in a stroke of superb timing we tagged the stock in our watchlist once again, and what it did next blew the run we witnessed in November right out of the water!  Coinciding with the announcement of positive top-line results on another of the company’s treatments (this one for autoimmune disease) ARNA made a huge intraday run from a low of 3.66 to all the way up to 6.09. That’s a hefty 66% increase in a single session, and it came on approximately 20X the 3-month average volume, so cheers are in order for anyone who took advantage of our timely alert!


Heritage Media Corp. HMCP

Since we mentioned HMCP for the first time on New Year’s Eve, the stock has provided us with a few quality swing-trade opportunities. That day the stock traded in a range from .0047 to .0068, an intraday gain of 45% In following sessions we then observed subsequent swings from .0037-.0064 (+73%) and .0034-.0062 (+82%) making HMCP a flipper’s dream.

As we point out on the snapshot below, what has formed on the chart is known as a bullish flag, which is known to be a signal of further gains. Couple that with an RSI that’s screaming toward the power zone, and it makes HMCP one that we’ll really need to watch closely as we head into week’s end.


Extended Watchlist:
BIND, BIOD, FOLD, NRX, CYRN, AVEO, ACUR, PLX, S

Blue Horseshoe Stocks: TWTR Options & More

Twitter, Inc. TWTR – Options Ideas

Toward the end of 2014, TWTR underwent a bit of a downturn on the heels of some insider selling and the general sluggishness of the market. The stock was beaten back into the low $35-range, and over the past couple of sessions it has done a good job of rebounding back to its highest level since the end of November. Our interest in TWTR relates specifically to the options chain, as we’ll look to take advantage of the recovery trend that’s currently in effect.

In particular the $38 (Closed @ 1.32) and $39 (Closed @ .83) Weekly Calls are catching our eye for a day-trading idea today. There is key resistance on the chart at the 50DMA 39.35, and in the premarket so far we’ve already seen trades as high as 39.60.  Therefore, we’re watching for some early morning profit taking followed by a rally, where those contracts may provide some intraday trading opportunities later in the day.

For more of a long-term swing-trade idea, we can monitor the February $40 Calls (Closed @ 2.70).



Frontline Ltd. FRO

FRO made a nice move for us after appearing in yesterday morning’s report; the stock traded in a daily range from 2.83 to 3.27 (+15%), and did so on healthy volume to the tune of roughly 9X the 3-month average. We continue to watch FRO this morning as it gaps up in the premarket, with trades already having gone off as high as 3.61, which represents an overall increase of 28% over yesterday’s observed low.

As noted in an article on The Street, some bullish comments made about FRO on CNBC yesterday could be partly responsible for the strong session.


Extended Watchlist:
JCP, GALT, ARNA, PKT, NLST

Blue Horseshoe Stocks: FCGD, PZOO Updates

First Columbia Gold Corp. FCGD

FCGD continued to push its limits on Friday; if you recall, the low we observed following our in our initial report last Monday was .075. We witnessed a subsequent run to .098, which was followed by a pullback to support at  .076. From that level on Friday, FCGD went to to set a new high in to the close (.105), an intraday gain of 38% on nearly twice the monthly average volume.

LINKS:

Our Exclusive Interview with FCGD’s New CEO Jason Castenir on Thursday provided over 20 minutes of exclusive content on FCGD, so go check it out.

View a copy of Monday’s Initial FCGD Report Here

MORE INFO @ FirstColombiaGold.com
or connect with FCGD on Facebook, Twitter and YouTube


Pazoo, Inc. PZOO

We’ve kept an active eye on PZOO since we introduced it to our reports two Mondays ago at a low of .0225. The stock has since established a higher level of support above the 50DMA, which was something we were looking to have happen.

We also saw PZOO achieve a new high last week, hitting .038 (A 69% increase from our observed low) a mark that will act as key resistance moving forward.

The company set a new traffic milestone for their online health and wellness portal as well, updating us of the achievement on Thursday:

WHIPPANY, NJ / ACCESSWIRE / October 30, 2014 / Pazoo, Inc. (PZOO) (German WKN#: A1J3DK) is pleased to report that traffic surged passed the previous high of 203,000 visitors in one day (previously recorded May of 2014) to 239,786 on October 27, 2014, as reported by Google Analytics. >> VIEW PR


Groupon, Inc. GRPN

We also need to pat ourselves on the back for taking a timely look at GRPN on Friday and mentioning it in our extended watchlist. The stock surged from a low of 6.45 and ended up peaking at 7.42, gaining 16.5% intraday on almost six times the one-month average volume.

That’s quite a respectable single-session spike from a stock in this price range.


Extended Watchlist:
GERN, OIBR, ARNA, MNDO, NYMX(Gap-down, Watching for Possible Reversal)

Blue Horseshoe Stocks: Momentum Play & More

Vision Plasma Systems, Inc. VLNX

We’ve got a sub-penny momentum play on our hands this morning in the form of VLNX. This volatile trader has been swinging violently over the past few months, sometimes more than a hundred percent at a time.

We’re going to have our eyes on VLNX as we close the book on another trading week; the stock came from beneath .001 yesterday and began to run, hitting a daily high of .0017. As you can see on the included chart below, a move past that point would open the door on much larger gains.

When VLNX has surged in recent months, it has routinely peaked in the .002-.004 range. A run back to those levels from here would provide a good chance for quick profits, and chart indicators are showing a forthcoming spike to be a distinct possibility.


FTE Networks, Inc. FTNW

We saw some action from FTNW after including it in yesterday’s report, as the stock offered up the opportunity for modest gains on the order of 23% intraday from .0303 to .04.

While the chart data shows that the stock hit highs in the .055-.065 range, those were what we refer to as “fat-finger prints”; blocks of such small volume so as to make them insignificant, since it would have been impossible to exit any sizable position at those prices.

Still, gains of up to 23%, which were possible, are nothing to thumb your nose at.


Extended Watchlist:
SGMS, ARNA, FSI, ARRY, PBR($16 calls for next week)

Get Our FREE Daily Reports!